Clinical trials
Hyperoxaluria, Primary trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 1 |
| 2021 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 1 |
| Recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alnylam Pharmaceuticals | 5 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 2 |
| OxThera | 2 |
| Arbor Biotechnologies | 1 |
| Biocodex | 1 |
| Novo Nordisk A/S | 1 |
| University Hospital, Strasbourg, France | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperoxaluria, Primary | 13 |
| Hyperoxaluria | 4 |
| Genetic Diseases, Inborn | 3 |
| Kidney Diseases | 3 |
| Urologic Diseases | 3 |
| Metabolic Diseases | 1 |
| Metabolism, Inborn Errors | 1 |
| Nephrocalcinosis | 1 |
| Renal Insufficiency | 1 |
| Urolithiasis | 1 |
Trials
Showing 26 to 13 of 13. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.